CONMED Corporation

CNMD Healthcare Medical Devices

CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024.

Revenue
−0.70%
EPS
+635.0%
Free cash flow
−3.65%
Total debt
−4.44%

Quarter to September 2026, against a year earlier

51.97 0.86 −1.63%
Market cap
$1.6B
P/E
21.7×
Fwd P/E
11.7×
Dividend yield
0.00%
F-score
5/9
Altman Z
1.86
Beneish M
−2.70
Dividend safety
63/100

CONMED Corporation (CNMD) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, CONMED Corporation (CNMD) trades at a P/E ratio of 21.7×. Over the past ten years it has ranged from 0.0× (June 2023) to 5,641× (December 2020); the current reading is higher than 22% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 26.9× 68.54%
FY2024 16.0× (69.43%)
FY2023 52.2× —
FY2022 0.0× —
FY2021 66.2× (80.48%)
FY2020 339× 209.56%
FY2019 110× 149.33%
FY2018 44.0× 72.90%
FY2017 25.4× (70.07%)
FY2016 85.0× 112.21%

Quarterly newest first

Period P/E ratio Change
Sep 2026 19.1× 7.91%
Jun 2026 17.7× (11.44%)
Mar 2026 20.0× (25.70%)
Dec 2025 26.9× 17.77%
43 more quarters

Against its own ten years

Low 0.0× High 5,641×
Ten-year median 46.3×
Current reading's percentile 17

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on CNMD